The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Feb 2017 10:44

RNS Number : 4547W
Seneca Global Income & Growth PLC
09 February 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Seneca Global Income & Growth Trust plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to thenotification obligation: iii

Seneca IM Limited

4. Full name of shareholder(s)  (if different from 3.):iv

See section 9 below

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

08/02/2017

6. Date on which issuer notified:

09/02/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Was 5.31%, Now 4.81%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0008769993

2,119,989

2,119,989

1,919,989

n/a

1,919,989

n/a

4.81%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

n/a

n/a

n/a

n/a

n/a

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,919,989

4.81%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Segregated Account

Bank of New York Nominees Ltd a/c 318901

250,011

CF Seneca Diversified Income Fund

Bank of New York Nominees Ltd a/c 392513

1,669,978

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a

13. Additional information:

14. Contact name:

Steven Cowie

15. Contact telephone number:

0131 538 1400

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKSRRBRAURAR
Date   Source Headline
18th May 20204:49 pmRNSTransaction in Own Shares
18th May 202012:24 pmRNSNet Asset Value(s)
15th May 202012:23 pmRNSNet Asset Value(s)
14th May 20204:26 pmRNSTransaction in Own Shares
14th May 202011:28 amRNSNet Asset Value(s)
13th May 20204:43 pmRNSTransaction in Own Shares
13th May 202011:36 amRNSNet Asset Value(s)
12th May 202012:02 pmRNSNet Asset Value(s)
11th May 20201:54 pmRNSNet Asset Value(s)
7th May 202011:47 amRNSNet Asset Value(s)
6th May 20204:51 pmRNSTransaction in Own Shares
6th May 202012:08 pmRNSNet Asset Value(s)
5th May 202012:27 pmRNSNet Asset Value(s)
4th May 20204:53 pmRNSTransaction in Own Shares
4th May 202012:42 pmRNSNet Asset Value(s)
1st May 20204:30 pmRNSTransaction in Own Shares
1st May 202012:40 pmRNSNet Asset Value(s)
1st May 20209:58 amRNSTotal Voting Rights
30th Apr 20204:53 pmRNSTransaction in Own Shares
30th Apr 202012:39 pmRNSNet Asset Value(s)
29th Apr 20204:46 pmRNSTransaction in Own Shares
29th Apr 202011:46 amRNSNet Asset Value(s)
28th Apr 20205:08 pmRNSTransaction in Own Shares
28th Apr 202011:49 amRNSNet Asset Value(s)
27th Apr 202011:58 amRNSNet Asset Value(s)
24th Apr 202012:18 pmRNSUpdate research from QuotedData
24th Apr 202010:33 amRNSNet Asset Value(s)
23rd Apr 202010:40 amRNSNet Asset Value(s)
22nd Apr 20205:25 pmRNSTransaction in Own Shares
22nd Apr 202012:36 pmRNSNet Asset Value(s)
21st Apr 20201:13 pmRNSNet Asset Value(s)
20th Apr 202012:10 pmRNSNet Asset Value(s)
17th Apr 20201:27 pmRNSNet Asset Value(s)
16th Apr 20201:50 pmRNSNet Asset Value(s)
15th Apr 202012:37 pmRNSNet Asset Value(s)
14th Apr 202012:54 pmRNSNet Asset Value(s)
9th Apr 20204:58 pmRNSTransaction in Own Shares
9th Apr 202011:10 amRNSNet Asset Value(s)
9th Apr 202010:11 amRNSDirector/PDMR Shareholding
8th Apr 202012:50 pmRNSNet Asset Value(s)
7th Apr 20204:55 pmRNSIssue of Equity
7th Apr 202011:18 amRNSNet Asset Value(s)
7th Apr 20207:00 amRNSDividend Declaration
6th Apr 20205:04 pmRNSTransaction in Own Shares
6th Apr 20201:05 pmRNSNet Asset Value(s)
3rd Apr 20204:51 pmRNSTransaction in Own Shares
3rd Apr 202012:15 pmRNSNet Asset Value(s)
2nd Apr 202012:07 pmRNSNet Asset Value(s)
1st Apr 202012:27 pmRNSNet Asset Value(s)
1st Apr 202011:24 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.